In fiscal year 2025, D&D Pharmatech (347850) reported revenue of 4.3 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 4.3 billion KRW | -34.0 billion KRW | -24.0 billion KRW | [source] |
| 2024 | 11.4 billion KRW | -25.0 billion KRW | -29.5 billion KRW | [source] |
| 2023 | 18.7 billion KRW | -13.5 billion KRW | 3.4 billion KRW | — |
| 2022 | 611 million KRW | -68.7 billion KRW | -137.0 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 170.3 billion KRW | 3.8 billion KRW | 166.5 billion KRW | [source] |
| 2024 | 126.9 billion KRW | 6.0 billion KRW | 120.9 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.